Bracco Company Profile
What is the competitive landscape for BRACCO
BRACCO has forty-three approved drugs.
There are three US patents protecting BRACCO drugs.
Summary for Bracco
| US Patents: | 3 |
| Tradenames: | 66 |
| Ingredients: | 33 |
| NDAs: | 43 |
Drugs and US Patents for Bracco
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bracco | IOMERVU | iomeprol | SOLUTION;INTRA-ARTERIAL | 216016-009 | Nov 27, 2024 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Bracco | ISOVUE-250 | iopamidol | INJECTABLE;INJECTION | 018735-007 | Jul 6, 1992 | AP | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bracco | IOMERVU | iomeprol | SOLUTION;INTRA-ARTERIAL | 216016-010 | Nov 27, 2024 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Bracco
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Bracco | CARDIOGEN-82 | rubidium chloride rb-82 | INJECTABLE;INJECTION | 019414-001 | Dec 29, 1989 | 4,562,829 | ⤷ Start Trial |
| Bracco | MULTIHANCE | gadobenate dimeglumine | INJECTABLE;INTRAVENOUS | 021357-002 | Nov 23, 2004 | 4,916,246 | ⤷ Start Trial |
| Bracco | PROHANCE | gadoteridol | INJECTABLE;INJECTION | 020131-001 | Nov 16, 1992 | 5,846,519 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Bracco Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Korea | 20220008277 | ⤷ Start Trial |
| European Patent Office | 3969065 | ⤷ Start Trial |
| China | 113811335 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Bracco Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2340828 | 2190001-4 | Sweden | ⤷ Start Trial | PRODUCT NAME: SACUBITRIL/VALSARTAN, AS SACUBITRIL VALSARTAN SODIUM SALT COMPLEX, I.E. (S)-N-VALERYL-N-2-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL-METHYL-VALINE) ((2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER)NA3 - X H2O, WHEREIN X IS 0 TO 3; REG. NO/DATE: EU/1/15/1058 20151123 |
| 1556389 | 16C0004 | France | ⤷ Start Trial | PRODUCT NAME: CEFTOLOZANE,EVENTUELLEMENT SOUS LA FORME D'UN SEL PHARMACEUTIQUEMENT ACCEPTABLE,PLUS PARTICULIEREMENT UN SEL D'ACIDE SULFURIQUE; REGISTRATION NO/DATE: EU/1/15/1032 20150922 |
| 3141251 | SPC/GB20/075 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: A MEDICINAL PRODUCT CONSISTING OF A COMBINATION OF A FIRST DOSE PHARMACEUTICAL COMPOSITION AND A SECOND DOSE PHARMACEUTICAL COMPOSITION, THE FIRST DOSE PHARMACEUTICAL COMPOSITION CONSISTING OF THE ACTIVE INGREDIENTS: POLYETHYLENE GLYCOL 3350, SODIUM SULPH; REGISTERED: IS IS/1/17/063/01 20171016; UK PL 20011/0040 20171016 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
